Tenecteplase-related clot migration does not create a “clinical penalty” for stroke thrombectomy patients

At this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (2–4 September, Marseille, France), NeuroNews spoke with Jildaz Caroff (Bicêtre Hospital, Paris, France) to discuss recent findings—published by the TETRIS study group in the Journal of NeuroInterventional Surgery—that elucidate the link between thrombectomy outcomes and tenecteplase (TNK)-related thrombus migration. Here, Caroff shares the motivation behind this study, its key results, and what these findings may mean for clinical practice.